Biotricity, Inc. (BTCY)
USD 0.35
(3.83%)
USD 0.35
(3.83%)
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2024 | 17.18 Million USD | -17.59% |
| 2023 | 20.85 Million USD | -2.14% |
| 2022 | 21.3 Million USD | 45.69% |
| 2021 | 14.62 Million USD | 28.1% |
| 2020 | 11.41 Million USD | 31.95% |
| 2019 | 8.65 Million USD | 12.02% |
| 2018 | 7.72 Million USD | 29.98% |
| 2017 | 5.94 Million USD | 15.83% |
| 2016 | 5.13 Million USD | 5625.58% |
| 2015 | 89.59 Thousand USD | -0.36% |
| 2014 | 89.92 Thousand USD | 0.0% |
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2024 FY | 17.18 Million USD | -17.59% |
| 2024 Q1 | 4.23 Million USD | 11.9% |
| 2024 Q3 | 3.44 Million USD | -17.57% |
| 2024 Q4 | 5.31 Million USD | 54.12% |
| 2024 Q2 | 4.18 Million USD | -1.14% |
| 2023 Q3 | 5.65 Million USD | 6.49% |
| 2023 Q2 | 5.3 Million USD | -0.09% |
| 2023 FY | 20.85 Million USD | -2.14% |
| 2023 Q1 | 5.31 Million USD | -18.93% |
| 2023 Q4 | 3.78 Million USD | -33.09% |
| 2022 Q4 | 6.55 Million USD | 17.88% |
| 2022 Q3 | 5.56 Million USD | -11.79% |
| 2022 Q2 | 6.3 Million USD | 51.07% |
| 2022 Q1 | 4.17 Million USD | 13.31% |
| 2022 FY | 21.3 Million USD | 45.69% |
| 2021 Q1 | 3.61 Million USD | -18.69% |
| 2021 FY | 14.62 Million USD | 28.1% |
| 2021 Q2 | 2.99 Million USD | -17.27% |
| 2021 Q3 | 4.01 Million USD | 34.25% |
| 2021 Q4 | 3.68 Million USD | -8.39% |
| 2020 Q2 | 2.23 Million USD | -1.16% |
| 2020 Q3 | 2.62 Million USD | 17.31% |
| 2020 FY | 11.41 Million USD | 31.95% |
| 2020 Q1 | 2.26 Million USD | 23.39% |
| 2020 Q4 | 4.45 Million USD | 69.41% |
| 2019 Q1 | 2.43 Million USD | -12.66% |
| 2019 FY | 8.65 Million USD | 12.02% |
| 2019 Q3 | 2.26 Million USD | 2.17% |
| 2019 Q2 | 2.21 Million USD | -9.18% |
| 2019 Q4 | 1.83 Million USD | -18.83% |
| 2018 Q1 | 1.38 Million USD | -10.64% |
| 2018 Q2 | 1.45 Million USD | 5.29% |
| 2018 Q3 | 2.09 Million USD | 44.04% |
| 2018 Q4 | 2.79 Million USD | 33.21% |
| 2018 FY | 7.72 Million USD | 29.98% |
| 2017 Q1 | 800.8 Thousand USD | 38.88% |
| 2017 Q4 | 1.54 Million USD | -29.46% |
| 2017 FY | 5.94 Million USD | 15.83% |
| 2017 Q3 | 2.19 Million USD | 56.24% |
| 2017 Q2 | 1.4 Million USD | 75.21% |
| 2016 Q2 | 1.22 Million USD | 149.3% |
| 2016 FY | 5.13 Million USD | 5625.58% |
| 2016 Q4 | 576.62 Thousand USD | -59.86% |
| 2016 Q3 | 1.43 Million USD | 17.11% |
| 2016 Q1 | 492.01 Thousand USD | 0.0% |
| 2015 Q1 | 27.64 Thousand USD | 0.0% |
| 2015 Q2 | 20.58 Thousand USD | -25.52% |
| 2015 Q3 | 18.9 Thousand USD | -8.18% |
| 2015 FY | 89.59 Thousand USD | -0.36% |
| 2014 FY | 89.92 Thousand USD | 0.0% |
| Name | Operating Expenses | Operating Expenses Difference |
|---|---|---|
| Acutus Medical, Inc. | 11.22 Million USD | -53.105% |
| Cerus Corporation | 143.15 Million USD | 87.996% |
| OrthoPediatrics Corp. | 137.01 Million USD | 87.458% |
| PetVivo Holdings, Inc. | 11.36 Million USD | -51.261% |
| Talis Biomedical Corporation | 67.18 Million USD | 74.422% |
| Vivos Therapeutics, Inc. | 24.94 Million USD | 31.113% |
| Inogen, Inc. | 236.08 Million USD | 92.721% |
| Spectral AI, Inc. | 20.86 Million USD | 17.635% |
| Nano-X Imaging Ltd. | 55.99 Million USD | 69.312% |
| CVRx, Inc. | 76.14 Million USD | 77.431% |
| DIH Holding US, Inc. Warrants | 3.52 Million USD | -387.091% |
| Helius Medical Technologies, Inc. | 12.48 Million USD | -37.597% |
| Orthofix Medical Inc. | 667.42 Million USD | 97.425% |
| Venus Concept Inc. | 80.47 Million USD | 78.646% |
| Accelerate Diagnostics, Inc. | 56.57 Million USD | 69.627% |
| Bioventus Inc. | 409.91 Million USD | 95.808% |
| BrainsWay Ltd. | 28.01 Million USD | 38.666% |
| Envoy Medical, Inc. | 17.89 Million USD | 3.986% |
| electroCore, Inc. | 32.03 Million USD | 46.35% |
| IceCure Medical Ltd | 16.87 Million USD | -1.828% |
| Lucid Diagnostics Inc. | 42.43 Million USD | 59.501% |
| Monogram Orthopaedics, Inc. | 17.63 Million USD | 2.543% |
| MaxCyte, Inc. | 84.84 Million USD | 79.746% |
| NeuroOne Medical Technologies Corporation | 12.41 Million USD | -38.454% |
| Nexalin Technology, Inc. | 5.78 Million USD | -197.241% |
| PAVmed Inc | 64.82 Million USD | 73.492% |
| Rapid Micro Biosystems, Inc. | 51.07 Million USD | 66.356% |
| RxSight, Inc. | 103.85 Million USD | 83.453% |
| Sight Sciences, Inc. | 126.44 Million USD | 86.41% |
| SI-BONE, Inc. | 156.35 Million USD | 89.009% |
| TELA Bio, Inc. | 84.18 Million USD | 79.588% |
| TriSalus Life Sciences, Inc. | 70.05 Million USD | 75.47% |
| Treace Medical Concepts, Inc. | 203.36 Million USD | 91.55% |
| LivaNova PLC | 843.54 Million USD | 97.963% |
| 908 Devices Inc. | 68.08 Million USD | 74.758% |
| Alphatec Holdings, Inc. | 483.59 Million USD | 96.447% |
| Nemaura Medical Inc. | 7.13 Million USD | -140.72% |
| NeuroPace, Inc. | 75.29 Million USD | 77.177% |
| LENSAR, Inc. | 33.33 Million USD | 48.45% |
| Apyx Medical Corporation | 51.01 Million USD | 66.317% |
| Cutera, Inc. | 197.72 Million USD | 91.309% |
| STRATA Skin Sciences, Inc. | 24.78 Million USD | 30.654% |
| BioSig Technologies, Inc. | 28.53 Million USD | 39.767% |
| Anika Therapeutics, Inc. | 191.47 Million USD | 91.025% |
| ClearPoint Neuro, Inc. | 36.06 Million USD | 52.345% |
| Integra LifeSciences Holdings Corporation | 836.39 Million USD | 97.945% |
| Axonics, Inc. | 270.2 Million USD | 93.64% |
| Outset Medical, Inc. | 198.77 Million USD | 91.355% |
| IRIDEX Corporation | 31.81 Million USD | 45.984% |
| PROCEPT BioRobotics Corporation | 180.21 Million USD | 90.465% |
| IRadimed Corporation | 30.12 Million USD | 42.952% |
| Tivic Health Systems, Inc. | 8.53 Million USD | -101.413% |
| INVO Bioscience, Inc. | 7.85 Million USD | -118.82% |
| Telesis Bio, Inc. | 63.48 Million USD | 72.933% |
| Viemed Healthcare, Inc. | 98.45 Million USD | 82.545% |
| Varex Imaging Corporation | 224.8 Million USD | 92.356% |
| Quipt Home Medical Corp. | 148.66 Million USD | 88.441% |
| Inspira Technologies Oxy B.H.N. Ltd. | 11.72 Million USD | -46.588% |
| Pulmonx Corporation | 112.68 Million USD | 84.75% |
| Dynatronics Corporation | 9.9 Million USD | -73.441% |
| Modular Medical, Inc. | 17.52 Million USD | 1.965% |
| ReShape Lifesciences Inc. | 20.18 Million USD | 14.873% |
| Semler Scientific, Inc. | 38.94 Million USD | 55.874% |
| InMode Ltd. | 215.68 Million USD | 92.032% |
| Bruker Corporation | 1.07 Billion USD | 98.404% |
| Cytosorbents Corporation | 48.33 Million USD | 64.448% |
| DexCom, Inc. | 1.69 Billion USD | 98.984% |
| Align Technology, Inc. | 2.07 Billion USD | 99.173% |
| Viveve Medical, Inc. | 22.17 Million USD | 22.498% |
| ZimVie Inc. | 275.12 Million USD | 93.754% |
| Movano Inc. | 29.69 Million USD | 42.12% |
| Cytek Biosciences, Inc. | 137.27 Million USD | 87.481% |
| Nexalin Technology, Inc. | 5.78 Million USD | -197.241% |
| DIH Holdings US, Inc. Class A Common Stock | 3.52 Million USD | -387.091% |
| Tandem Diabetes Care, Inc. | 600.92 Million USD | 97.14% |
| Profound Medical Corp. | 33.6 Million USD | 48.86% |
| Insulet Corporation | 939.9 Million USD | 98.172% |
| enVVeno Medical Corporation | 25.23 Million USD | 31.91% |
| Surmodics, Inc. | 98.69 Million USD | 82.589% |
| iCAD, Inc. | 22.22 Million USD | 22.679% |
| Nuwellis, Inc. | 22.61 Million USD | 24.006% |
| iRhythm Technologies, Inc. | 445.88 Million USD | 96.146% |
| Aethlon Medical, Inc. | 12.27 Million USD | -39.968% |
| InspireMD, Inc. | 22.95 Million USD | 25.122% |
| PAVmed Inc. | 64.82 Million USD | 73.492% |
| BIOLASE, Inc. | 34.66 Million USD | 50.421% |
| Beyond Air, Inc. | 61.7 Million USD | 72.148% |
| FONAR Corporation | 28.6 Million USD | 39.924% |
| AxoGen, Inc. | 149.33 Million USD | 88.493% |
| Vivani Medical, Inc. | 26.96 Million USD | 36.271% |
| Tactile Systems Technology, Inc. | 177.09 Million USD | 90.296% |
| Inari Medical, Inc. | 448.59 Million USD | 96.169% |
| UFP Technologies, Inc. | 58.08 Million USD | 70.417% |
| QT Imaging Holdings, Inc. | 4.92 Million USD | -248.741% |
| Heart Test Laboratories, Inc. | 6.31 Million USD | -171.981% |
| Tenon Medical, Inc. | 16.96 Million USD | -1.276% |
| Autonomix Medical, Inc. Common Stock | 7.39 Million USD | -132.444% |
| Co-Diagnostics, Inc. | 44.1 Million USD | 61.035% |
| AdaptHealth Corp. | 1.07 Billion USD | 98.406% |
| Sintx Technologies, Inc. | 15.2 Million USD | -13.049% |
| NanoVibronix, Inc. | 4.97 Million USD | -245.557% |
| Quanterix Corporation | 118.1 Million USD | 85.449% |
| Inspira Technologies Oxy B.H.N. Ltd. | 11.72 Million USD | -46.588% |
| Sensus Healthcare, Inc. | 14.44 Million USD | -18.99% |
| Pacific Biosciences of California, Inc. | 392.66 Million USD | 95.624% |
| TransMedics Group, Inc. | 182.82 Million USD | 90.6% |
| ReWalk Robotics Ltd. | 28.06 Million USD | 38.769% |
| NeuroMetrix, Inc. | 11.09 Million USD | -54.831% |
| Hyperfine, Inc. | 52.87 Million USD | 67.498% |
| Establishment Labs Holdings Inc. | 172 Million USD | 90.009% |
| Biomerica, Inc. | 6.97 Million USD | -146.268% |
| Bone Biologics Corporation | 9.42 Million USD | -82.266% |
| AVITA Medical, Inc. | 80.77 Million USD | 78.727% |
| Bluejay Diagnostics, Inc. | 10.31 Million USD | -66.659% |
| Silk Road Medical, Inc | 186.35 Million USD | 90.779% |